Search
Drug Impact Events
| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 9/20/17 | GlaxoSmithKline (GSK) | Trelegy Ellipta for Chronic Obstructive Pulmonary Disease (COPD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/20/17 | Alnylam (ALNY) | Patisiran for Transthyretin (TTR)-related Hereditary Amyloidosis (Familial Amyloid Polyneuropathy) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/19/17 | Pfizer (PFE) | Sutent for Renal Cell Cancer (RCC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/19/17 | Amicus Therapeutics (FOLD) | Galafold for Fabry's Disease | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/18/17 | GlaxoSmithKline (GSK) | Trelegy Ellipta for Chronic Obstructive Pulmonary Disease (COPD) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 09/21/17 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 09/21/17 | Subscribers Only | Subscribers Only | Trial Data - Other |
| 09/21/17 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/21/17 | Subscribers Only | Subscribers Only | Progress Update - Development Review |
| Now - 09/22/17 | Subscribers Only | Subscribers Only | Regulatory - Supplemental Approval (Europe) |
Special Reports
28.jpg "Pipeline Drugs for Respiratory Syncytial Virus, Phase II-III")
26.jpg "Hormone Refractory Prostate Cancer Therapies, Phase III & Pivotal Phase II")
27.jpg "Pancreatic Cancer Therapies, Phase III & Pivotal Phase II")
Latest Pharma Insights
BioMedTracker in the News
| Date | Headline |
|---|---|
| 09/15/17 | Market watch: Upcoming market catalysts in Q4 2017 |
| 06/16/17 | Market watch: Upcoming market catalysts in Q3 2017 |
| 03/17/17 | Market watch: Upcoming market catalysts in Q2 2017 |
| 12/29/16 | Market watch: Upcoming market catalysts in Q1 2017 |
| more... | |